Philippe Moerman Selected Research

Oxygen (Dioxygen)

11/2008

The addition of 4% oxygen to the CO(2) pneumoperitoneum does not decrease dramatically port site metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Moerman Research Topics

Disease

25	Neoplasms (Cancer) 05/2018 - 11/2005
8	Endometrial Neoplasms (Endometrial Cancer) 10/2016 - 09/2007
6	Carcinoma (Carcinomatosis) 01/2018 - 12/2008
4	Sarcoma (Soft Tissue Sarcoma) 03/2017 - 12/2008
4	Breast Neoplasms (Breast Cancer) 08/2014 - 01/2008
4	Ovarian Neoplasms (Ovarian Cancer) 09/2013 - 11/2008
3	Adenosarcoma 03/2017 - 03/2003
3	Carcinosarcoma 01/2017 - 02/2011
3	Endometrioid Carcinoma 10/2016 - 12/2008
2	Hydatidiform Mole (Molar Pregnancy) 01/2018 - 08/2016
2	Endometrial Stromal Sarcoma 03/2017 - 12/2006
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 12/2015
2	Microsatellite Instability 10/2016 - 10/2015
2	Adenocarcinoma 10/2016 - 01/2008
2	Abscess 08/2015 - 11/2006
2	Neoplasm Metastasis (Metastasis) 10/2013 - 11/2008
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2018
1	Leiomyosarcoma 03/2017
1	Smooth Muscle Tumor 03/2017
1	Margins of Excision 01/2017
1	Papillary Cystadenoma 10/2016
1	Choriocarcinoma 08/2016
1	Tics (Tic) 08/2016
1	Persistent Fetal Circulation Syndrome 05/2016
1	Aneuploidy (Aneuploid) 09/2015
1	Wounds and Injuries (Trauma) 08/2015
1	Ovarian Epithelial Carcinoma 12/2014
1	Brain Neoplasms (Brain Tumor) 03/2014
1	Uterine Neoplasms (Uterine Cancer) 12/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2011
1	Kidney Diseases (Kidney Disease) 01/2011
1	Carcinogenesis 12/2008
1	Triple Negative Breast Neoplasms 11/2008
1	Pneumoperitoneum 11/2008
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 10/2008
1	Pseudomyxoma Peritonei 10/2006

Drug/Important Bio-Agent (IBA)

6	Progesterone Receptors (Progesterone Receptor)IBA 10/2016 - 06/2004
4	human ERBB2 proteinIBA 10/2016 - 04/2008
4	PlatinumIBA 12/2014 - 04/2009
4	Estrogen ReceptorsIBA 02/2011 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 11/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 03/2014
3	Estrogens (Estrogen)FDA Link 10/2016 - 06/2004
3	ParaffinIBA 03/2014 - 12/2008
3	Hormones (Hormone)IBA 12/2006 - 03/2003
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2014
2	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2014
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 12/2004
2	Messenger RNA (mRNA)IBA 12/2013 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 02/2011 - 04/2009
1	Keratin-7 (Cytokeratin 7)IBA 05/2018
1	Keratin-20 (Cytokeratin 20)IBA 05/2018
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2017
1	Ifosfamide FDA LinkGeneric 01/2017
1	Phenobarbital (Luminal)FDA Link 10/2016
1	Trastuzumab (Herceptin)FDA Link 10/2016
1	IGF-I-IGFBP-3 complex FDA Link 10/2016
1	Methotrexate (Mexate)FDA LinkGeneric 08/2016
1	Etoposide (VP 16)FDA LinkGeneric 08/2016
1	Long Noncoding RNAIBA 05/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	AZD 6244IBA 10/2015
1	VimentinIBA 10/2015
1	dactolisibIBA 10/2015
1	Keratins (Keratin)IBA 10/2015
1	dichlorobis(azomycin)platinum IIIBA 09/2015
1	Circulating Tumor DNAIBA 09/2015
1	Carbon DioxideIBA 08/2015
1	P-2 (P 2)IBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	Formaldehyde (Formol)FDA Link 03/2014
1	VaccinesIBA 12/2013
1	Taxoids (Taxanes)IBA 08/2011
1	TubulinIBA 08/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2011
1	Imatinib Mesylate (Gleevec)FDA Link 02/2011
1	StathminIBA 02/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2011
1	TOR Serine-Threonine KinasesIBA 02/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Transcription Factors (Transcription Factor)IBA 12/2008
1	Oxygen (Dioxygen)IBA 11/2008

Therapy/Procedure

9	Therapeutics 01/2017 - 11/2006
4	Adjuvant Chemotherapy 02/2013 - 09/2007
3	Neoadjuvant Therapy 01/2017 - 10/2013
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2015
2	Lymph Node Excision (Lymph Node Dissection) 12/2015 - 08/2014
2	Immunotherapy 12/2013 - 09/2013
2	Lasers (Laser) 01/2011 - 04/2009
1	Salpingo-oophorectomy 01/2018
1	Chemoradiotherapy 01/2017
1	Curettage 08/2016
1	Hysterectomy 12/2015
1	Molecular Targeted Therapy 03/2014
1	Laparotomy 11/2008
1	Orchiopexy 10/2008
1	Orchiectomy (Orchidectomy) 10/2008
1	Conservative Treatment 01/2008
1	Radiotherapy 09/2007